High-frequency identification of monetary policy shocks in Japan. [PDF]
Jpn Econ Rev (Oxf), 2022 Kubota H, Shintani M.
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
Unveiling the monetary policy rule in the Euro-area
, 2011 Thanassis Kazanas, Elias Tzavalis
openalex +1 more source
Modeling Two Macro Policy Instruments - Interest Rates and Aggregate Capital Requirements [PDF]
We present a simple neoclassical model to explore how an aggregate bank-capital requirement can be used as a macroeconomic policy tool and how this additional tool interacts with monetary policy.
Hans Gersbach, Volker Hahn
core
Monetary policy reaction function: A Bayesian analysis for the BRICS. [PDF]
PLoS OneWaheed F, Rashid A, Basit A, Maroof L.
europepmc +1 more source
COVID-19 and Exchange Rates: Spillover Effects of U.S. Monetary Policy. [PDF]
Atl Econ J, 2022 Yilmazkuday H.
europepmc +1 more source
The changing U.S. financial system : some implications for the monetary transmission mechanism [PDF]
An important part of monetary policy is the monetary transmission mechanism, the process by which monetary policy actions influence the economy. While the transmission mechanism involves a number of channels, including exchange rates, bank credit, and ...
Gordon H. Sellon, Jr.
core
Financial stability in sub-Saharan Africa: Does monetary policy matter? [PDF]
HeliyonZanfack LT +3 more
europepmc +1 more source
Relationship between financial inclusion, monetary policy and financial stability: An analysis in high financial development and low financial development countries. [PDF]
Heliyon, 2023 Oanh TTK, Van LTT, Dinh LQ.
europepmc +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source